Home > Drug Search >
  • company_query: Amarantus BioScience
  •   > 
Drug Filter
Category:
chemistry (28) biology (9)
Status:
Approved (11) NDA Filing (3) Phase Ⅲ (8) Phase Ⅱ (11) Phase Ⅰ (4)
Clinical Stage:
Pending (3) Active (18) Discontinued (5)
Bio-Type:
Vaccine (1) Blood extraction (1) Recombinant enzyme (2) Other recombinant protein (1) ADC (1) Fusion protein (1)
Indication:
Meningitis (1) Acute myeloid Leukemia (AML) (1) Advanced breast cancer (1) Alcohol dependence (1) Alzheimer's disease (AD) (1) Anemia (1) Arrhythmia (1) Tachyarrhythmia (1) Attention deficit hyperactivity disorder (ADHD) (1) Breast cancer (2) Poisoning (1) Chronic lymphocytic leukemia (CLL) (1) Guillain-Barre syndrome (1) Cognitive disorders (1) Lyme disease (1) Dry eye disease (1) Transplant rejection (1) Gastric cancer (1) Hepatocellular carcinoma (HCC) (2) HIV infection (1) Tumour lysis syndrome (1) Hypertension (1) Leukemia (1) Lung cancer (2) Lymphoma (2) Malignancies (1) Metastatic prostate carcinoma (1) Metastatic melanoma (1) Multiple myeloma (MM) (1) Myelofibrosis (1) Non small cell lung cancer (NSCLC) (1) Ovarian cancer (1) Pancreatic cancer (1) Bone disorders (1) Peripheral  neuropathy (1) Prostate cancer (1) Small cell lung cancer (SCLC) (1) Solid tumours (1) Tardive dyskinesia (1) Nasopharyngeal cancer (1) Respiratory depression (1) Testicular cancer (1) Muscle hypertonia (1) Neuroblastoma (1) Pain (3) Anesthesia (3) Sarcoma (1) Gastroesophageal junction adenocarcinoma (1) Mycosis fungoides (1) Lower urinary tract symptoms (LUTS) (1) Leishmaniasis (1) Glioblastoma (1) Gout (1) Burns (1) Cocaine abuse (1) Chemotherapy induced poisoning (1) Immunodeficiency disorders (1) Psychiatric disorders (1) Immune thrombocytopenic purpura (1)
Aprv. Year:
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top